Axonal conduction and injury in multiple sclerosis: The role of sodium channels

Nature Reviews Neuroscience

Volumn 7, Issue 12, 2006, Pages 932-941

  Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL;

AXONAL INJURY; CELL PROLIFERATION; CELL TYPE; CEREBELLUM DEGENERATION; DEMYELINATION; GENE TARGETING; GENETIC TRANSFECTION; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; REVIEW;

ACTION POTENTIALS; ANIMALS; AXONS; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; NEURAL CONDUCTION; SODIUM CHANNELS; WALLERIAN DEGENERATION;

EID: 33751180140     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn2023     Document Type: Review

References (92)

1. Ritchie, J. M. & Rogart, R. B. The density of sodium channels in mammalian myelinated nerve fibers and the nature of the axonal membrane under the myelin sheath. Proc. Natl Acad. Sci. USA 74, 211-215 (1997).
2. + channels, which are aggregated in the nodal axon membrane of myelinated axons.
3. Ulrich, J. & Groebke-Lorenz, W. The optic nerve in MS: a morphological study with retrospective clinicopathological correlation. Neurol. Ophthalmol. 3, 149-159 (1983).
4. Bostock, H. & Sears, T. A. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J. Physiol. 280, 273-301 (1978).
5. + channels in densities sufficient to support conduction.
6. Novakovic, S. D., Levinson, S. R., Schachner, M. & Shrager, P. Disruption and reorganization of sodium channels in experimental allergic neuritis. Muscle Nerve 21, 1019-1032 (1998).
7. England, J. D., Gamboni, F. & Levinson, S. R. Increased numbers of sodium channels form along demyelinated axons. Brain Res. 548, 334-337 (1991).
8. Moll, C., Mouvre, C., Lazdunski, M. & Ulrich, J. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res. 556, 311-316 (1991).
9. Trapp, B. D. et al. Axonal transection in the lesions of multiple sclerosis. New Engl. J. Med. 338, 278-285 (1998). Discusses the time course and the frequency of axonal degeneration in MS.
10. Kuhlmann, T., Lingfeld, G., Bitsch, A., Schuchardt, J. & Bruck, W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125, 2202-2212 (2002).
11. Davie, C. et al. Functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118, 1583-1592 (1995).
12. Wujek, J. R. et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J. Neuropathol. Exp. Neurol. 61, 23-32 (2002).
13. 2+ exchange which injures axons.
14. + conductance in rat optic nerve axons. Proc. Natl Acad. Sci. USA 90, 6976-6980 (1993).
15. LoPachin, R. M. Jr & Stys, P. K. Elemental composition and water content of rat optic nerve myelinated axons and glial cells: effects of in vitro anoxia and reoxygenation J. Neurosci. 15, 6735-6746 (1995).
16. Stys, P. K., Ransom, B. R. & Waxman, S. G. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J. Neurophysiol. 67, 236-240 (1992).
17. Fern, R., Ransom, B. R., Stys, P. K. & Waxman, S. G. Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam. J. Pharmacol. Exper. Ther. 266, 1549-1555 (1993).
18. Lo, A. C., Black, J. A. & Waxman, S. G. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J. Neurophysiol. 90, 3566-3572 (2003).
19. + channel blockers.
20. Smith, K. J. & Lassmann, H. The role of NO in multiple sclerosis. Lancet Neurol. 1, 232-241 (2002).
21. Brown, G. C. & Bal-Price, A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol. Neurobiol. 27, 325-355 (1989).
22. + channel blockers protect axons from NO-induced injury.
23. Garthwaite, G., Goodwin, D. A., Batchelor, A. M., Leeming, K. & Garthwaite, J. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 109, 145-155 (2002).
24. Dutta R. et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann. Neurol. 59, 478-489 (2006).
25. Catterall W. A., Goldin A. L. & Waxman, S. G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57, 397-409 (2005).
26. Waxman, S. G., Black, J. A., Kocsis, J. D. & Ritchie, J. M. Low density of sodium channels supports action potential conduction in axons of neonatal rat optic nerve. Proc. Natl Acad. Sci. USA 86, 1406-1410 (1989).
27. Boiko, T. et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 30, 91-104 (2001).
28. v1.6 at developing CNS nodes of Ranvier. Neuron 30, 105-119 (2001).
29. Foster, R. E., Connors, B. R. & Waxman, S. G. Rat optic nerve: electrophysiological, pharmacological and anatomical studies during development. Dev. Brain Res. 3, 361-376 (1982).
30. Rasband, M. N. et al. Dependence of nodal sodium channel clustering on paranodal axo-glial contact in the developing CNS. J. Neurosci. 19, 7516-7528 (1999).
31. + channel subtypes in central neurons. Neuron 3, 695-704 (1989).
32. Boiko, T. et al. Functional specialization of the axon initial segment by isoform-specific sodium channel targeting. J. Neurosci. 23, 2306-2313 (2003).
33. + channel at the nodes of Ranvier.
34. Craner, M. J., Lo, A. C., Black, J. A. & Waxman, S. G. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination. Brain 126, 1552-1562 (2003).
35. + channel isoforms along demyelinated CNS axons in EAE, and shows the association of Nav1.6 with axonal injury.
36. Black, J. A. et al. Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J. Neurophysiol. 82, 2776-2785 (1999).
37. Rush, A. M., Dib-Hajj, S. D. & Waxman, S. G. Electrophysiological properties of two axonal sodium channels, Nav1.2 and Nav1.6, expressed in spinal sensory neurons. J. Physiol. 564, 803-816 (2005).
38. Lassmann, H. in Multiple Sclerosis as a Neuronal Disease (ed. Waxman, S. G.) 153-165 (Elsevier Science, Amsterdam, 2005).
39. + channel isoforms along demyelinated axons in MS.
40. Bhat, M. A. et al. Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron 30, 369-383 (2001).
41. + channel α-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J. Comp. Neurol. 412, 342-352 (1999).
42. Whitaker, W. R. et al. Distribution of voltage-gated sodium channel α-subunit and β-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. J. Comp. Neurol. 422, 123-139 (2000).
43. Iwata, A. et al. Traumatic axonal injury induces proteolytic cleavage of the voltage-gated sodium channels modulated by tetrodotoxin and protease inhibitors. J. Neurosci. 24, 4605-4613 (2004).
44. Herzog, R. I., Liu, C., Waxman, S. G. & Cummins, T. R. Calmodulin binds to the C terminus of sodium channels Nav1.4 and Nav1.6 and differentially modulates their functional properties. J. Neurosci. 23, 8261-8270 (2003).
45. Waxman, S. G., Davis, P. K., Black, J. A. & Ransom, B. R. Anoxic injury of mammalian central white matter: decreased susceptibility in myelin-deficient optic nerve. Ann. Neurol. 28, 335-340 (1990).
46. Imaizumi, T., Kocsis, J. D. & Waxman, S. G. Resistance to anoxic injury in rat spinal cord following demyelination. Brain Res. 779, 292-296 (1998).
47. DeLuca, G. C., Williams, K., Evangelou, N., Ebers, G. C. & Esiri, M. M. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 129, 1507-1516 (2006).
48. 2+ exchanger in mammalian myelinated axons. Brain Res. 776, 1-9 (1997).
49. Matthews, W. B., Compston, A., Allen, I. V. & Martyn, C. N. McAlpine's Multiple Sclerosis (Churchill Livingstone, New York, 1991).
50. Andermann, F., Cosgrove, J. B. R., Lloyd-Smith, D. & Walters, A. M. Paroxysmal dysarthria and ataxia in multiple sclerosis; a report of 2 unusual cases. Neurology 9, 211-215 (1959).
51. Espir, M. L., Watkins, S. M. & Smith, H. V. Paroxysmal dysarthria and other transient neurological disturbances in disseminated sclerosis. J. Neurol. Neurosurg. Psychiat. 29, 323-330 (1966).
52. Waxman, S. G. Cerebellar dysfunction in multiple sclerosis: evidence for an acquired channelopathy. Prog. Brain Res. 148, 353-365 (2005).
53. Black, J. A. et al. Abnormal expression of SNS/PN3 sodium channel in cerebellar Purkinje cells following loss of myelin in the Taiep rat. NeuroReport 10, 913-918 (1999).
54. + channel Nav1.8 in Purkinje cells in EAE and MS.
55. Okuse, K. et al. AnnexinII light chain regulates sensory neuron-specific sodium channel expression. Nature 47, 653-656 (2002).
56. Craner, M. J. et al. Annexin II/p11 is up-regulated in Purkinje cells in EAE and MS. NeuroReport 14, 555-558 (2003).
57. Akopian, A. N., Sivilotti, L. & Wood, J. N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379, 257-262 (1996).
58. Sangameswaren, L. et al. Structure and function of a novel voltage-gated tetrodotoxin-resistant sodium channel specific to sensory neurons. J. Biol. Chem. 271, 5953-5956 (1996).
59. Elliott, A. A. & Elliott, J. R. Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J. Physiol. (Lond.) 463, 93-56 (1993).
60. Dib-Hajj, S. D., Ishikawa, I., Cummins, T. R. & Waxman, S. G. Insertion of an SNS-specific tetrapeptide in the S3-S4 linker of D4 accelerates recovery from inactivation of skeletal muscle voltage-gated Na channel μ1 in HEK293 cells. FEBS Letts. 416, 11-14 (1997).
61. v1.8 sodium channels to action potential electrogenesis in DRG neurons. J. Neurophysiol. 86, 629-640 (2001).
62. 2+ current in the action potentials of nociceptive sensory neurons. J. Neurosci. 22, 10277-10290 (2002).
63. Llinas, R. & Sugimori, M. Electrophysiological properties of in vitro Purkinje cell somata in mammalian cerebellar slices J. Physiol. 305, 171-195 (1980).
64. Stuart, G. & Hausser, M. Initiation and spread of sodium action potentials in cerebellar purkinje cells. Neuron 13, 703-712 (1994).
65. Raman, I. M., Sprunger, L. K., Meisler, M. H. & Bean, B. P. Altered subthreshold sodium currents and disrupted firing patterns in Purkinje neurons of Scn81 mutant mice. Neuron 19, 881-891 (1997).
66. Kohrman, D. C., Smith, M. R., Goldin, A. L., Harris, J. & Meisler, M. H. A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting. J. Neurosci. 16, 5993-5999 (1996).
67. v1.8 sodium channels perturbs the firing patterns of cerebellar Purkinje cells. Brain Res. 959, 235-243 (2003).
68. Saab, C. V., Craner, M. J., Kataoka, Y. & Waxman, S. G. Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis, in preparation. Exp. Brain Res. 158, 1-8 (2004).
69. + channel III and SNS gene expression in spinal sensory neurons. Neuroreport 8, 2331-2335 (1997).
70. Dib-Hajj, S. D. et al. Rescue of α-SNS sodium channel expression in small dorsal root ganglion neurons after axotomy by nerve growth factor in vivo. Neurophysiology 79, 2668-2676 (1998).
71. Laudiero, L. B. et al. Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci. Lett. 147, 9-12 (1992).
72. DeSimone, R., Micera, A., Tirassa, P. & Aloe, L. mRNA for NGF and p75 in the central nervous system of rats affected by experimental allergic encephalomyelitis. Neuropathol. Appl. Neurobiol. 22, 54-59 (1996).
73. v1.8 in Purkinje neurons in experimental autoimmune encephalomyelitis. Neurosci. Lett. 369, 186-190 (2004).
74. Muragaki, Y. et al. Expression of trk receptors in the developing and adult human central and peripheral nervous system J. Comp. Neurol. 356, 387-397 (1995).
75. Yan, Q. & Johnson, E. M. Jr. An immunohistochemical study of the nerve growth factor receptor in developing rats. J. Neurosci. 8, 3481-3498 (1988).
76. Soilu-Hanninen, M. et al. Treatment of experimental autoimmune encephalomyelitis with antisense oligonucleotides against the low affinity neurotrophin receptor. J. Neurosci. Res. 59, 712-721 (2001).
77. Craner, M. J. et al. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia, 49, 220-229 (2005). Demonstration of upregulated expression of Nav1.6 channels in microglia and macrophages in EAE and MS, and of their role in microglial/macrophage activation and phagocytosis.
78. Ferguson, B., Matyszak, M. K., Esiri, M. M. & Perry, V. H. Axonal damage in acute multiple sclerosis lesions. Brain 120, 393-399 (1997).
79. Kornek, B. et al. Multiple sclerosis and chronic autoimmuno encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive and remyelinated lesions. Am. J. Pathol. 157, 267-276 (2000).
80. + T lymphocytes in the cenetral nervous system. Clin. Exp. Immunol. 98, 313-318 (1994).
81. Renno, T., Krakowski, M., Piccirillo, C., Lin, J. Y. & Owens, T. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154, 944-953 (1995).
82. Hooper, D. C. et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl Acad. Sci. USA 94, 2528-2533 (1997).
83. DeGroot, C. J. et al. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of netric oxide synthase in demyelinating multiple sclerosis lesions. Neuropathol. Exp. Neurol. 56, 10-20 (1997).
84. Matsumoto Y., Ohmori, Y. & Fujiwara, K. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 76, 209-216 (1992).
85. Li, H., Cuzner, M. L. & Newcombe, J. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 22, 207-215 (1996).
86. Korotzer, A. R. & Cotman, C. W. Voltage-gated currents expressed by rat microglia in culture. Glia 6, 81-88 (1992).
87. Nörenberg W., Illes, P. & Gebicke-Haeter, P. J. Sodium channels in isolated human brain macrophages (microglia). Glia 10, 165-172 (1994).
88. Black, J. A., Liu, S., Hains, B. C., Saab, C. Y. & Waxman, S. G. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain 24 Aug 2006 (doi:10.1093/brain/aw1216).
89. + channel in an HLA-DR-restricted human T cell clone. J. Immunol. 165, 83-90 (2000).
90. + influx in human T cells: role in T cell activation. J. Neuroimmunol. 99, 53-60 (1999).
91. Waxman, S. G., Demyelination in spinal cord injury and multiple sclerosis: what can we do to enhance functional recovery? J. Neurotrauma 9, S105-S117 (1992).
92. Popovich, P. G. & Jones, T. B. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 24, 13-17 (2003).